Procalcitonin and Respiratory Tract Infections
Can't see this email? View it online
   
  July 23, 2018  
  Respiratory Diseases  
  The latest respiratory diseases news from News Medical  
 Procalcitonin and Respiratory Tract InfectionsProcalcitonin and Respiratory Tract Infections
 
Procalcitonin is a peptide biomarker used in the diagnosis of a number of infectious conditions. Detection of procalcitonin indicates the presence of inflammation, and is thus often used to diagnose respiratory tract infections.
 
 Pulmonary Rehabilitation for COPD
 
Pulmonary Rehabilitation for COPDPulmonary rehabilitation is an 8-12 week program encompassing several aspects of pulmonary care for the improvement of lung function in patients with COPD.
 
 
 Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD)
 
Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD)Acute Exacerbations of COPD (AECOPD) are acute episodes of breathlessness and sputum production associated with chronic obstructive pulmonary disorder.
 
 Lung Plethysmography Procedure
 
Lung Plethysmography ProcedureSimilar to spirometry and pulse oximetry, lung plethysmography is a tool within the broad umbrella of pulmonary function tests. It is a type of diagnostic procedure used to measure the amount of air in the lungs after inhalation or exhalation.
 
 
 Phenotyping of Chronic Obstructive Pulmonary Disease (COPD)
 
Phenotyping of Chronic Obstructive Pulmonary Disease (COPD)Chronic obstructive pulmonary disease (COPD) is a group of syndromes which depict common general symptoms, but differ in several more detailed aspects.
 
 
 Asthma Triggers
 
Asthma TriggersThe effective management of asthma largely depends on identifying and managing underlying trigger. This article describes the well-known triggers for asthma and how to avoid them.
 
 
 Four-protein biomarker blood test improves lung cancer risk assessment for smokers
 
Four-protein biomarker blood test improves lung cancer risk assessment for smokersA four-protein biomarker blood test improves lung cancer risk assessment over existing guidelines that rely solely upon smoking history, capturing risk for people who have ever smoked, not only for heavy smokers, an international research team reports in JAMA Oncology.